Pablo Diez-Villanueva
Overview
Explore the profile of Pablo Diez-Villanueva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
875
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alonso Salinas G, Martinez Leon A, Aguiar Cano D, Esteban-Fernandez A, Vieitez Florez J, Del Prado Diaz S, et al.
ESC Heart Fail
. 2025 Feb;
PMID: 40017333
Aims: Information about current use of finerenone in patients with heart failure (HF) finerenone in clinical practice is scarce, and its effectiveness in clinical practice in patients is scarce. We...
2.
Negreira-Caamano M, Diez-Delhoyo F, Cepas-Guillen P, Lopez-Lluva M, Jurado-Roman A, Bazal-Chacon P, et al.
Rev Esp Cardiol (Engl Ed)
. 2025 Feb;
PMID: 39954993
Introduction And Objectives: Arrhythmias such as atrial fibrillation and atrial flutter (AF/AFl) complicate the management of patients with non-ST-segment elevation acute coronary syndrome (NSTEACS). The aim of this study was...
3.
Nunez J, Minana G, de la Espriella R, Zegri-Reiriz I, Comin-Colet J, Rubio Gracia J, et al.
Eur J Heart Fail
. 2025 Feb;
PMID: 39933832
Aims: The efficacy of combining hypertonic saline solution (HSS) with loop diuretics in worsening heart failure (WHF) remains uncertain. Hypochloraemia has been associated with reduced diuretic efficacy. Some authors propose...
4.
Esteban-Fernandez A, Recio-Mayoral A, Lopez-Vilella R, de Lara G, Barrantes-Castillo M, Gomez-Otero I, et al.
Front Cardiovasc Med
. 2025 Jan;
11():1504427.
PMID: 39850382
Introduction: Vericiguat, an oral stimulator of soluble guanylate cyclase, reduces cardiovascular mortality and hospitalisations in patients with heart failure (HF) and reduced ejection fraction, as demonstrated in the VICTORIA trial....
5.
Different impact of chronic kidney disease in older patients with heart failure according to frailty
Diez-Villanueva P, Jimenez-Mendez C, Perez-Rivera A, Barge Caballero E, Lopez J, Ortiz C, et al.
Eur J Intern Med
. 2024 Dec;
132:90-96.
PMID: 39648049
Background: Chronic kidney disease (CKD) and frailty are often present in older patients with heart failure (HF). Our aim was to evaluate the association of CKD and frailty in one-year...
6.
Routine invasive strategy and frailty burden in non-ST-segment elevation acute myocardial infarction
Ariza-Sole A, Andres Bermeo J, Formiga F, Bueno H, Minana G, Alegre O, et al.
J Geriatr Cardiol
. 2024 Dec;
21(10):954-961.
PMID: 39619358
Objective: To assess the prognostic impact of a routine invasive strategy according to the frailty burden in patients with non-ST-segment elevation myocardial infarction (NSTEMI) from the MOSCA-FRAIL clinical trial. Methods:...
7.
Vera A, Cecconi A, Martinez-Vives P, Lopez-Melgar B, Olivera M, Hernandez S, et al.
Heart Vessels
. 2024 Oct;
PMID: 39375197
Introduction: Differentiation of tachycardia-induced cardiomyopathy (TIC) from dilated cardiomyopathy (DCM) in patients admitted for heart failure (HF) with left ventricular dysfunction and supraventricular tachyarrhythmia (SVT) remains challenging. The role of...
8.
Goirigolzarri-Artaza J, Cobo-Marcos M, Pena-Conde L, Villa A, Iglesias D, Esteban-Fernandez A, et al.
Rev Cardiovasc Med
. 2024 Oct;
25(9):328.
PMID: 39355595
Background: Self-care and empowerment promotion in patients with heart failure (HF) is essential for improving their prognosis, but there is limited information concerning the patients' depth of knowledge about this...
9.
Sanchis J, Bueno H, Garcia-Blas S, Gomez-Hospital J, Marti D, Martinez-Selles M, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Sep;
PMID: 39270775
Introduction And Objectives: Invasive management in frail patients with non-ST-segment elevation myocardial infarction (NSTEMI) remains controversial. We investigated the impact of various geriatric conditions. Methods: The MOSCA-FRAIL trial included 167...
10.
Diez-Villanueva P, Jimenez-Mendez C, Cepas-Guillen P, Arenas-Loriente A, Fernandez-Herrero I, Garcia-Pardo H, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200201
Cardiovascular disease constitutes the leading cause of morbimortality worldwide. Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is a common cardiovascular condition, closely related to the ageing population and significantly affecting survival...